Publications by authors named "Zachary Acker"
Article Synopsis
- The study assessed an unsupervised COVID-19 testing method where university participants self-swabbed at their convenience compared to traditional supervised testing.
- Over the academic year from September 2021 to July 2022, unsupervised self-swabs were notably less frequent (26,800) than supervised ones (92,499), with higher error rates in unsupervised tests.
- Results indicated that younger participants and certain racial/ethnic groups were more likely to choose unsupervised testing, with a drop in errors for unsupervised tests as time progressed—showing increasing feasibility over time.
Introduction: Although SARS-CoV-2 vaccines were first approved under Emergency Use Authorization by the Food and Drug Administration in late 2020 for adults, authorisation for young children 6 months to <5 years of age did not occur until 2022. These authorisations were based on clinical trials, understanding real-world vaccine effectiveness (VE) in the setting of emerging variants is critical. The primary goal of this study is to evaluate SARS-CoV-2 VE against infection among children aged >6 months and adults aged <50 years.
View Article and Find Full Text PDF